Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
VENUSREM | NSE
-3.65
-1.05%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
19/09/2024
343.50
356.00
356.00
342.00
Venus Remedies Limited develops and markets pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas such as analgesic analgesic and antipyretic anti-diabetic antibiotic anticoagulant cardiac disinfectant and antiseptic gastro therapy hand sanitizers hormones iron supplements neurology oncology pain management respiratory skin and wound care stress reliever urology and vitamins/minerals/nutrients as well as antimicrobial resistance products. It also provides disinfectants; and a portfolio of herbal products. Venus Remedies Limited was incorporated in 1989 and is headquartered in Panchkula India.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Price Below SMA10D
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
22.2%1 month
24.1%3 months
39.6%6 months
43.1%17.16
-
0.98
0.08
0.07
6.08
0.73
-
614.93M
4.62B
55.23M
-
4.86
4.50
14.10
6.01
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
28.00
Range1M
36.95
Range3M
100.05
Rel. volume
0.55
Price X volume
9.13M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Brooks Laboratories Limited | BROOKS | Drug Manufacturers-Specialty & Generic | 153.56 | 4.03B | -2.00% | n/a | 8.60% |
Medico Remedies Limited | MEDICO | Drug Manufacturers-Specialty & Generic | 48 | 3.84B | 3.23% | 41.94 | 15.37% |
Par Drugs And Chemicals Limited | PAR | Drug Manufacturers-Specialty & Generic | 234.05 | 2.94B | -2.01% | 22.25 | 0.00% |
Alpa Laboratories Limited | ALPA | Drug Manufacturers-Specialty & Generic | 114.72 | 2.48B | -0.24% | 14.11 | 3.45% |
Vaishali Pharma Limited | VAISHALI | Drug Manufacturers-Specialty & Generic | 192.25 | 2.06B | -1.98% | 333.23 | 31.49% |
Mangalam Drugs & Organics Limited | MANGALAM | Drug Manufacturers-Specialty & Generic | 127.32 | 2.02B | -6.02% | n/a | 72.53% |
Bal Pharma Limited | BALPHARMA | Drug Manufacturers-Specialty & Generic | 127.24 | 2.01B | -3.31% | 27.01 | 201.53% |
Krebs Biochemicals & Industries Limited | KREBSBIO | Drug Manufacturers-Specialty & Generic | 90.59 | 1.96B | -2.00% | n/a | -162.25% |
Bafna Pharmaceuticals Limited | BAFNAPH | Drug Manufacturers-Specialty & Generic | 79.14 | 1.89B | 658.33 | 30.17% | |
Aarey Drugs & Pharmaceuticals Limited | AAREYDRUGS | Drug Manufacturers-Specialty & Generic | 66.39 | 1.86B | -3.31% | 34.02 | 23.61% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Bhagyanagar India Ltd | BHAGYANGR | Copper | 102.27 | 3.27B | -3.96% | 34.15 | 52.08% |
Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 166.42 | 1.85B | -3.27% | 49.20 | 4.88% |
Cubex Tubings Limited | CUBEXTUB | Copper | 93.74 | 1.34B | -3.01% | 34.07 | 21.78% |
Madhav Copper Limited | MCL | Copper | 36.42 | 1.02B | -1.33% | n/a | 32.70% |
Sagardeep Alloys Limited | SAGARDEEP | Copper | 28.12 | 483.23M | 88.75 | 43.14% | |
Heads UP Ventures Limited | HEADSUP | Apparel Retail | 14.67 | 331.86M | -1.48% | n/a | 0.00% |
Suumaya Industries Limited | SUULD | Apparel Retail | 4.93 | 296.65M | -2.38% | n/a | -118.72% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 6.08 | 23.29 | Cheaper |
Ent. to Revenue | 0.73 | 12.02 | Cheaper |
PE Ratio | 17.16 | 47.84 | Cheaper |
Price to Book | 0.98 | 6.55 | Cheaper |
Dividend Yield | - | 0.59 | - |
Std. Deviation (3M) | 39.57 | 40.95 | Par |
Debt to Equity | 0.08 | 0.34 | Cheaper |
Debt to Assets | 0.07 | 0.17 | Cheaper |
Market Cap | 4.62B | 286.13B | Emerging |